ArticleInternational journal of cancer2010

MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.

Minu K Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.